Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

JNJ 99.17 -0.33 (-0.33%)
price chart
Johnson & Johnson to Remove Formaldehyde From Products
Johnson & Johnson, which makes a range of personal care products like baby shampoo, acne cream and antiwrinkle lotion, announced plans Wednesday to remove a host of potentially harmful chemicals, like formaldehyde, from its line of consumer products ...
Johnson & Johnson to Remove Formaldehyde, Other Chemicals from Products  TIME
How Johnson & Johnson is cutting out toxics  GreenBiz.com
Related articles »  
Johnson & Johnson Announces a Ban on Harmful Chemicals in Products
Johnson & Johnson made the landmark announcement this week that it would ban harmful chemicals from their products. The company has already made the pledge to remove toxic chemicals from its baby products by 2013.
The Real Lesson of Formaldehyde In Baby Shampoo  TIME
Time for companies to pledge to remove dangerous chemicals from products  Fox News
Related articles »  
Johnson & Johnson Eyes China's Baby Market
Johnson & Johnson is rumored to be considering the acquisition of a local baby-care product vendor Shanghai Elsker in China, a move that could strengthen its foothold in the rapidly-growing Chinese baby-care market.
Johnson & Johnson Still Hates Women With Heavier Than Normal Periods
Last year the internet was in an uproar because Johnson & Johnson discontinued OB Ultra Absorbency tampons. By internet, I mean women's sites, of course.
Trials for Alzheimer's Drug Halted After Poor Results
Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer's drug after two clinical trials failed to show that it was effective in patients with mild to moderate forms of the disease.
Pfizer, J&J end development of once-promising Alzheimer's drug  The Star-Ledger - NJ.com
Lilly Last Hope for Alzheimer's as Pfizer-J&J Bow Out  Bloomberg
Related articles »  
Johnson & Johnson unit recalls bone putty
The health regulator said certain lots of bone putty made by Johnson & Johnson unit Synthes were recalled as there was potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during surgery.
Related articles »  
Johnson & Johnson agrees to pay $181 million to settle multistate litigation ...
Johnson & Johnson will pay $181 million to resolve claims by 36 states that it improperly advertised the antipsychotic drugs Risperdal and Invega, New York Attorney General Eric Schneiderman and the company said.
Johnson Johnson subsidiary to pay record amount to settle off-label ...  Seattle Post Intelligencer (blog)
Johnson & Johnson subsidiary settles deceptive marketing case for $181M  Healthcare Finance News
Related articles »  
Johnson & Johnson says it has tentative settlement with Justice officials over ...
Johnson & Johnson has ´┐Żan agreement in principle'' with the U.S. Justice Department to settle claims it inappropriately marketed the antipsychotic drug Risperdal and two other medicines, according to documents filed yesterday with federal securities ...
Related articles »  
Why Did Warren Buffett Sell Johnson & Johnson?
Warren Buffett made lots of headlines when it was disclosed that he had made substantial liquidations of several long-term stock holdings.
Related articles »  
Johnson & Johnson releases some Doxil for trials
Manufacturing problems at a Boehringer Ingelheim plant did a double whammy on Johnson & Johnson's ($JNJ) cancer drug, Doxil.
Related articles »